126 related articles for article (PubMed ID: 38142581)
1. Fluorinated curcumin derivative (Shiga-Y6) modulates the level of thioredoxin-interacting protein (TXNIP) in a mouse model of diabetes.
Aldoghachi AF; Yanagisawa D; Pahrudin Arrozi A; Abu Bakar ZH; Taguchi H; Ishigaki S; Morino K; Tooyama I
Biochem Biophys Res Commun; 2024 Jan; 694():149392. PubMed ID: 38142581
[TBL] [Abstract][Full Text] [Related]
2. Novel fluorinated derivative of curcumin negatively regulates thioredoxin-interacting protein expression in retinal pigment epithelial and macrophage cells.
Buyandelger U; Walker DG; Taguchi H; Yanagisawa D; Tooyama I
Biochem Biophys Res Commun; 2020 Nov; 532(4):668-674. PubMed ID: 32912630
[TBL] [Abstract][Full Text] [Related]
3. A Fluorine-19 Magnetic Resonance Probe, Shiga-Y5, Downregulates Thioredoxin-Interacting Protein Expression in the Brain of a Mouse Model of Alzheimer's Disease.
Pahrudin Arrozi A; Abu Bakar ZH; Taguchi H; Yanagisawa D; Tooyama I
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500775
[TBL] [Abstract][Full Text] [Related]
4. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
5. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
6. Alpha Cell Thioredoxin-interacting Protein Deletion Improves Diabetes-associated Hyperglycemia and Hyperglucagonemia.
Lu B; Chen J; Xu G; Grayson TB; Jing G; Jo S; Shalev A
Endocrinology; 2022 Oct; 163(11):. PubMed ID: 35957590
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes.
Chen J; Hui ST; Couto FM; Mungrue IN; Davis DB; Attie AD; Lusis AJ; Davis RA; Shalev A
FASEB J; 2008 Oct; 22(10):3581-94. PubMed ID: 18552236
[TBL] [Abstract][Full Text] [Related]
8. Lack of TXNIP protects beta-cells against glucotoxicity.
Shalev A
Biochem Soc Trans; 2008 Oct; 36(Pt 5):963-5. PubMed ID: 18793170
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin-interacting protein regulates insulin transcription through microRNA-204.
Xu G; Chen J; Jing G; Shalev A
Nat Med; 2013 Sep; 19(9):1141-6. PubMed ID: 23975026
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis.
Chen J; Saxena G; Mungrue IN; Lusis AJ; Shalev A
Diabetes; 2008 Apr; 57(4):938-44. PubMed ID: 18171713
[TBL] [Abstract][Full Text] [Related]
11. Decreasing Txnip mRNA and protein levels in pancreatic MIN6 cells reduces reactive oxygen species and restores glucose regulated insulin secretion.
Rani S; Mehta JP; Barron N; Doolan P; Jeppesen PB; Clynes M; O'Driscoll L
Cell Physiol Biochem; 2010; 25(6):667-74. PubMed ID: 20511712
[TBL] [Abstract][Full Text] [Related]
12. Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways.
Hong K; Xu G; Grayson TB; Shalev A
J Biol Chem; 2016 Apr; 291(16):8428-39. PubMed ID: 26858253
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic β-cells.
Luo Y; He F; Hu L; Hai L; Huang M; Xu Z; Zhang J; Zhou Z; Liu F; Dai YS
PLoS One; 2014; 9(6):e99049. PubMed ID: 24897113
[TBL] [Abstract][Full Text] [Related]
14. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice.
Qin K; Zhang N; Zhang Z; Nipper M; Zhu Z; Leighton J; Xu K; Musi N; Wang P
Diabetologia; 2018 Apr; 61(4):906-918. PubMed ID: 29322219
[TBL] [Abstract][Full Text] [Related]
15. Preventing β-cell loss and diabetes with calcium channel blockers.
Xu G; Chen J; Jing G; Shalev A
Diabetes; 2012 Apr; 61(4):848-56. PubMed ID: 22442301
[TBL] [Abstract][Full Text] [Related]
16. Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death.
Chen J; Fontes G; Saxena G; Poitout V; Shalev A
Diabetes; 2010 Feb; 59(2):440-7. PubMed ID: 19875615
[TBL] [Abstract][Full Text] [Related]
17. Deletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy.
Abdelsaid MA; Matragoon S; Ergul A; El-Remessy AB
PLoS One; 2014; 9(10):e110388. PubMed ID: 25329456
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
19. Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention.
Basnet R; Basnet TB; Basnet BB; Khadka S
Curr Drug Targets; 2022; 23(7):761-767. PubMed ID: 35240955
[TBL] [Abstract][Full Text] [Related]
20. Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell.
Shalev A
Mol Endocrinol; 2014 Aug; 28(8):1211-20. PubMed ID: 24911120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
